Prilosec Case Could Go To Trial After Decision On Inclusion Of Process Patent

A district court decision on whether to include an AstraZeneca process patent for Prilosec in pending patent litigation could be the final step before the company's patent infringement case against Andrx moves to trial.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet